Recurrent respiratory papillomatosis (RRP) is a rare disease. However, it is the most common benign laryngeal tumor in children. To date, no epidemiological data are available in France. The aim of this study is to establish the epidemiology of juvenile PPR.
Recurrent respiratory papillomatosis (RRP) is characterized by the recurrent proliferation of multiple polypoid squamous tumors in the respiratory tract, linked to HPV infection. RRP is a rare disease. However, it is the most common benign laryngeal tumor in children. There are currently no French national epidemiological data on this disease. The data collected by the reference centers will enable us to gain a better understanding of this pathology in terms of epidemiology, risk factors, genetic susceptibility and clinical manifestations, as well as to significantly study the efficacy of the various existing therapies and preventive measures, in order to establish a clear, standardized and optimal guideline.
Study Type
OBSERVATIONAL
Enrollment
200
hôpital Necker Enfants malades
Paris, France
RECRUITINGEpidemiology of juvenile RRP in France by clinical information
age at onset of disease, symptoms, severity score, intensity of disease characterized by need for endoscopies
Time frame: 10 years
Epidemiology of juvenile PRR in France according to vaccine and adjuvant therapeutic information
Vaccination and adjuvant therapy information
Time frame: 10 years
Epidemiology of juvenile PRR in France by paraclinical information
results of pulmonary imaging, genetic, anatomopathological and immunological tests
Time frame: 10 years
Define standardized management of juvenile RRP
Correlations between disease progression and frequency of follow-up, as well as treatments implemented (therapeutic or surgical interventions)
Time frame: 10 years
Therapeutic management of RRP
* Frequency of therapeutic surgery * Use of adjuvant therapies
Time frame: 10 years
Prevention of RRP
Analysis of national vaccination coverage with a vaccine immunizing against HPV 6 and 11
Time frame: 10 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.